Results 221 to 230 of about 461,308 (260)

HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment [PDF]

, 2018
DiPersio, John F., Gao, Feng, Liu, Chang, Rimando, Joseph, Romee, Rizwan, Slade, Michael, Westervelt, Peter   +6 more
core   +1 more source

Efficacy of therapeutic strategies on thrombocytopenia after hematopoietic stem cell transplantation-an evidence-based meta-analysis. [PDF]

Ther Adv Hematol
Hua W, Chen Y, Qi J, Song X, Zhou M, Han Y.   +5 more
europepmc   +1 more source

Prognostic impact of valemetostat in relapsed/refractory adult T‐cell leukaemia‐lymphoma

British Journal of Haematology, EarlyView.
Summary The prognosis for patients with relapsed/refractory (R/R) adult T‐cell leukaemia‐lymphoma (ATL) remains dismal. Recently, valemetostat, a dual inhibitor for enhancer of zeste homologue (EZH) 1 and 2, was approved in Japan for R/R aggressive ATL. However, there is no real‐world data on the efficacy and prognosis of valemetostat.
Takafumi Shichijo, Hiro Tatetsu, Yusuke Higuchi, Toshikazu Miyakawa, Kisato Nosaka, Takahisa Nakamura, Shinya Endo, Asami Yamada, Atsushi Wada, Yuki Okamoto, Toshiro Kawakita, Hitoshi Suzushima, Masao Matsuoka, Jun‐ichirou Yasunaga   +13 more
wiley   +1 more source

Allogeneic Hematopoietic Stem Cell Transplantation as a Platform to Treat Chemorefractory Acute Myeloid Leukemia in Adult Patients. [PDF]

Cancers (Basel)
Alzetta D, Cavattoni IM, Mosna F.
europepmc   +1 more source

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients. [PDF]

Front Immunol
Astarloa-Pando G, Sandá V, Amarilla-Irusta A, Lopez-Pardo A, San Juan I, Iturbe-Larrondo A, Pérez-Garay R, Pérez-Fernández S, Santos-Zorrozúa B, Manzanares-Martín B, Bernardo R, González C, Uranga A, Rey M, Alonso M, Amutio E, Mateos-Mazón JJ, García-Ruiz JC, Zenarruzabeitia O, Amo L, Borrego F.   +20 more
europepmc   +1 more source

Risk factors for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation: a systematic review and meta-analysis. [PDF]

BMC Pulm Med
Pu G, Nong G, Wei Q, He Y, Jia W, Lu Z, Qiu G, Xie J, Chen X.   +8 more
europepmc   +1 more source

Preface to Special Issue: Advances in hematopoietic stem cell transplantation for high-risk hematologic malignancies. [PDF]

Chin J Cancer Res
Huang X.
europepmc   +1 more source

UHRF2 as a genetic correlate of hospitalization in sickle cell disease

British Journal of Haematology, EarlyView.
Mina Cintho Ozahata, Monike Oliveira, Isabel Gomes, Cláudia Maximo, Alessandra Ferraz, André Rolim Belisário, Daiane Souza, Natalia A. Braga, Ester Sabino, Brian Custer, Shannon Kelly, Carla Luana Dinardo, for the REDS‐III Brazil SCD Cohort study and the TOPMed consortium   +12 more
wiley   +1 more source

Survival risk prediction in hematopoietic stem cell transplantation for multiple myeloma. [PDF]

J Integr Bioinform
Belmonte JM, Blanquer M, Bernabé G, Jiménez F, García JM.   +4 more
europepmc   +1 more source

Primary CD34+ cells of patients with vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK‐243

British Journal of Haematology, EarlyView.
Daniel Nowak, Marie Demmerle, Alessa Klär, Alexander Streuer, Vladimir Riabov, Eva Altrock, Felicitas Rapp, Ann‐Christin Belzer, Teresa Klink, Meret Hahn, Franziska Hofmann, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Melda Göl, Ali Darwich, Laurenz Steiner, Mohammed Abba, Georgia Metzgeroth, Wolf‐Karsten Hofmann, Nanni Schmitt   +21 more
wiley   +1 more source